In this task, you are given a summary for US Congressional and California state bill, your task is to generate a Title for this bill. The preferred titles are under forty words and mention the purpose of the bill.

Example Input: Amends the Elementary and Secondary Education Act of 1965 to establish a new program for teacher recruitment, retention, and training. Authorizes the Secretary of Education to award grants to local educational agencies to recruit, retain, and train high-quality teachers through one or more specified types of activities.Amends the Higher Education Act of 1965 to revise student loan forgiveness for teachers under the Federal Family Education Loan and Federal Direct Loan programs. Expands forgiveness eligibility by: (1) eliminating requirements allowing only certain new borrowers to participate; and (2) increasing the types of eligible teaching locations and subjects. Eliminates a service requirement that an individual teach at least five consecutive complete school years before being eligible for program benefits. Increases to $20,000 the aggregate amount of an individual teacher's student loan obligation which may be forgiven, and revises the rate of repayment.
Example Output: To amend the Elementary and Secondary Education Act of 1965 to provide grants to local educational agencies for teacher recruitment, retention, and training, and to amend the Higher Education Act of 1965 to expand the program of loan forgiveness for teachers.

Example Input: Authorizes the Secretary, acting through the Director of the Agency, to establish a program under which funding will be provided for at least 15 demonstration projects to be competitively awarded in health care facilities and organizations in geographically diverse locations to determine the causes of medical errors and develop specified methods to reduce, minimize, and provide for reporting and corrective action of, such errors. Provides that at least five of such projects shall require participating health care providers to report adverse events and health- or medication-related errors to the patient and patient's family member. Permits the use of reported information only for purposes of evaluating the ability to reduce errors in delivery of care. Subjects such information to confidentiality requirements and makes it inadmissible as evidence in any civil or criminal action. Prohibits disclosure of such information under the Freedom of Information Act as well.
Directs the Secretary to: (1) provide for establishment of a national database of medical errors to contain information collected under this Act; (2) provide information to educate patients and family members about their role in reducing medical errors; (3) develop programs that encourage patients to take a more active role in their medical treatment; and (4) make grants to health professional associations and other organizations to provide training in ways to reduce medical errors.
Requires the Secretary to report to appropriate congressional committees on: (1) costs associated with implementing a program that identifies factors that contribute to errors and which includes upgrading the heath care computer systems and other technologies in the United States to reduce medical errors; and (2) the success of each demonstration project, data collected by States, best methods for reducing medical errors and costs associated with applying such methods, and sharing information on best practices to reduce such errors in Federal health care programs.
Authorizes appropriations.
Example Output: Medical Error Reduction Act of 2000

Example Input: Amends the Federal Food, Drug, and Cosmetic Act (FFDCA) to establish a specific definition for "human tissue" which expressly excludes vascularized human organs, gene therapy, blood, soluble blood components, milk, or products made by combining human tissue with biomaterials.  Declares that human tissue is not a drug, biological product, or device unless reclassified under this Act. 
Amends the Public Health Service Act (PHSA) to subject human tissue to regulation under such Act only if voluntary regulation is inadequate, or if it is reclassified as a drug, biological product, or device pursuant to specified guidelines established by this Act. 
Requires any person subject to such regulation who recovers, processes, stores, or distributes human tissue for transplantation or implantation in the United States to register in accordance with FFDCA drug registration procedures.  Deems registrants to be authorized to conduct human tissue recovery, processing, storage, and distribution activities identified as applicable on the registration, unless, among other things, the Secretary of Health and Human Services suspends or revokes such authority after determining that the registrant fails to meet operating standards established by the Secretary. 
Prescribes certain human tissue labeling and advertising requirements. 
Authorizes the Secretary to reclassify human tissue as a drug, biological product, or device in specified circumstances. 
Outlines the mechanism for enforcement of this Act in the event that any violations of it constitute a significant risk to the public health. 
Subjects registrants to inspections under the Act. 
Applies the PHSA to umbilical cord blood to the same extent as it applies to human tissue. 
Prohibits the Secretary from regulating eyes until voluntary regulation is inadequate to protect the public health.
Example Output:
A bill to provide for the regulation of human tissue for transplantation to ensure that such tissue is handled in a manner to preserve its safety and purity, and for other purposes.

